Combined CD4+ Donor Lymphocyte Infusion and Low-Dose Recombinant IL-2 Expand FOXP3+ Regulatory T Cells following Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 3, 2009, Pages 382-388

  Zorn, Emmanuel ^a   Mohseni, Mehrdad ^a   Kim, Haesook ^a   Porcheray, Fabrice ^a   Lynch, Allison ^a   Bellucci, Roberto ^a   Canning, Christine ^a   Alyea, Edwin P ^a   Soiffer, Robert J ^a   Ritz, Jerome ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Allogeneic hematopoietic stem cell transplantation; CD4+CD25+ regulatory T cells; Donor lymphocyte infusion; FOXP3; IL 2

Indexed keywords

CYCLOPHOSPHAMIDE; RECOMBINANT INTERLEUKIN 2; TRANSCRIPTION FACTOR FOXP3;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CORRELATION ANALYSIS; DONOR LYMPHOCYTE INFUSION; DRUG ERUPTION; DRUG MECHANISM; FATIGUE; GENE EXPRESSION REGULATION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOMODULATION; LEUKEMIA; LONG TERM CARE; LOW DRUG DOSE; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBPOPULATION; MONOTHERAPY; MYALGIA; MYELOABLATIVE CONDITIONING; NAUSEA; PHASE 1 CLINICAL TRIAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; WHOLE BODY RADIATION;

ADOPTIVE TRANSFER; ADULT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY;

EID: 59349091835     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.12.494     Document Type: Article

References (26)

1. + regulatory T cells and graft-versus-host disease. Semin Hematol 43 (2006) 62-69
2. Cohen J.L., Trenado A., Vasey D., Klatzmann D., and Salomon B.L. CD4(+)CD25(+) immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med 196 (2002) 401-406
3. Edinger M., Hoffmann P., Ermann J., et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 9 (2003) 1144-1150
4. Jones S.C., Murphy G.F., and Korngold R. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response. Biol Blood Marrow Transplant 9 (2003) 243-256
5. Trenado A., Charlotte F., Fisson S., et al. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 112 (2003) 1688-1696
6. Miura Y., Thoburn C.J., Bright E.C., et al. Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood 104 (2004) 2187-2193
7. Zorn E., Kim H.T., Lee S.J., et al. Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood 106 (2005) 2903-2911
8. Hess A.D. Modulation of graft-versus-host disease: role of regulatory T lymphocytes. Biol Blood Marrow Transplant 12 Suppl 2 (2006) 13-21
9. Zorn E. CD4+CD25+ regulatory T cells in human hematopoietic cell transplantation. Semin Cancer Biol 16 (2006) 150-159
10. Hoffmann P., Boeld T.J., Eder R., et al. Isolation of CD4+CD25+ regulatory T cells for clinical trials. Biol Blood Marrow Transplant 12 (2006) 267-274
11. Karakhanova S., Munder M., Schneider M., Bonyhadi M., Ho A.D., and Goerner M. Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease. J Immunother 29 (2006) 336-349
12. Ahmadzadeh M., and Rosenberg S.A. IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients. Blood 107 (2006) 2409-2414
13. Zhang H., Chua K.S., Guimond M., et al. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4(+)CD25(+) regulatory T cells. Nat Med 11 (2005) 1238-1243
14. Zorn E., Nelson E.A., Mohseni M., et al. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 108 (2006) 1571-1579
15. Soiffer R.J., Fairclough D., Robertson M., et al. CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission. Blood 89 (1997) 3039-3047
16. Soiffer R.J., Murray C., Mauch P., et al. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow. J Clin Oncol 10 (1992) 1191-1200
17. Soiffer R.J., Murray C., Cochran K., et al. Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation. Blood 79 (1992) 517-526
18. Soiffer R.J., Murray C., Gonin R., and Ritz J. Effect of low-dose interleukin-2 on disease relapse after T-cell-depleted allogeneic bone marrow transplantation. Blood 84 (1994) 964-971
19. Alyea E.P., Soiffer R.J., Canning C., et al. Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. Blood 91 (1998) 3671-3680
20. Soiffer R.J., Alyea E.P., Hochberg E., et al. Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion. Biol Blood Marrow Transplant 8 (2002) 625-632
21. Zorn E., Wang K.S., Hochberg E.P., et al. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells. Clin Cancer Res 8 (2002) 2052-2060
22. Yamaguchi T., and Sakaguchi S. Regulatory T cells in immune surveillance and treatment of cancer. Semin Cancer Biol 16 (2006) 115-123
23. Rieger K., Loddenkemper C., Maul J., et al. Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD. Blood 107 (2006) 1717-1723
24. Sanchez J., Casano J., Alvarez M.A., et al. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol 126 (2004) 697-703
25. Godfrey W.R., Ge Y.G., Spoden D.J., et al. In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 104 (2004) 453-461
26. Hoffmann P., Eder R., Kunz-Schughart L.A., Andreesen R., and Edinger M. Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 104 (2004) 895-903